Are you Dr. Naeim?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 87 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 Medical 530 420 120 Plz
# 365
Los Angeles, CA 90095Phone+1 310-825-6301Fax+1 310-825-8918
Summary
- Dr. Arash Naeim, MD is an oncologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is affiliated with Ronald Reagan UCLA Medical Center and UCLA Medical Center-Santa Monica.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1998 - 2002
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Geriatric Medicine (Internal Medicine), 1997 - 1998
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1995 - 1997
- David Geffen School of Medicine at UCLAClass of 1995
Certifications & Licensure
- CA State Medical License 1997 - 2025
- American Board of Preventive Medicine Clinical Informatics
Clinical Trials
- Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer Start of enrollment: 2006 Mar 01
- COVID-19 Recovered Volunteer Research Participant Pool Registry Start of enrollment: 2020 Apr 08
Publications & Presentations
PubMed
- Relationship Between Perceived COVID-19 Risk and Change in Perceived Breast Cancer Risk: Prospective Observational Study.Ryan Baxter-King, Arash Naeim, Tina Q Huang, Karen Sepucha, Annette Stanton
JMIR Cancer. 2024-12-02 - Leave no one behind: A global survey of the current state of geriatric oncology practice by SIOG national representatives.Tomonori Mizutani, Kwok-Leung Cheung, Yervand Hakobyan, Heather Lane, Lore Decoster
Journal of Geriatric Oncology. 2024-03-01 - 1 citationsPerceptions of COVID-19 Risk: How Did People Adapt to the Novel Risk?Karen Sepucha, Aaron Rudkin, Ryan Baxter-King, Annette L Stanton, Neil Wenger
Medical Decision Making. 2024-02-01
Press Mentions
- Stanford Medicine Named Winner of the 2023 Hearst Health Prize in Partnership with the UCLA Center for SMART HealthMay 12th, 2023
- Breast Cancer Risk Models May Incorrectly Classify Many WomenFebruary 14th, 2023
- Constant Therapy Wins $100K Hearst Health Prize at UCLA HealthNovember 3rd, 2022
- Join now to see all
Grant Support
- Treatment Of Older Patients With Early Breast CancerNational Cancer Institute2003–2007